UNSPSC 51283219: Mepartricin b

This classification denotes a macrolide antibiotic with the molecular formula C59H86N2O19, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21G4VMN6C9, chemically known as candicidin d, 40-demethyl-3,7-dideoxo-3,7-dihydroxy-5-oxo-, methyl ester, cyclic 15,19-hemiacetal, but more generally known as mepartricin b, which bears US NIH Compound Identifier 6450330. European Medicines Agency schedules mepartricin b or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03153MIG.

Most nations, for tariff purposes, schedule mepartricin b under HS 29419000. SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC\2CC3C(C(CC(O3)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC(C(/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C)C(C)CCC(CC(=O)C4CCC(CC4)N)O)O)O)O)O)O)O)O)C(=O)OC)O)N)O.

UNSPSC 51283219 Mepartricin b is a Commodity code that covers pharmaceutical products procured by state and local health agencies, though recent solicitations tagged under this code reflect a broader range of medications and public health supplies rather than mepartricin specifically. State and local governments use this code to acquire emergency pharmaceuticals, antimicrobial agents, and harm-reduction supplies through piggyback purchasing arrangements and competitive bidding. The issuing bodies are primarily state health departments and county health authorities pursuing supplies for public health stockpiling, community health programs, and emergency preparedness. Purchasing mechanisms include cooperative consortia (such as MMCAP Infuse) that allow agencies to leverage existing vendor contracts and master agreements, reducing procurement cycle time and administrative burden.

Activity under the code centers on Illinois and Florida. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, totaling $2,999,999.11 over a 12-month initial term with two one-year renewal options; this was a completed award, not an open solicitation. Seminole County, Florida released an IFB (60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, including all shipping and delivery costs in vendor pricing. Both procurements emphasize fixed-fee pricing, compliance with federal regulations where FEMA funding is involved, and vendor credentialing (E-Verify, drug-free workplace certification, insurance requirements).